BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25569285)

  • 1. High-performance liquid chromatography-tandem mass spectrometry method for the determination of perampanel, a novel α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist in human plasma.
    Mano Y; Takenaka O; Kusano K
    J Pharm Biomed Anal; 2015 Mar; 107():56-62. PubMed ID: 25569285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPLC with fluorescence detection assay of perampanel, a novel AMPA receptor antagonist, in human plasma for clinical pharmacokinetic studies.
    Mano Y; Takenaka O; Kusano K
    Biomed Chromatogr; 2015 Oct; 29(10):1589-93. PubMed ID: 25828925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Liquid Chromatography-Mass Spectrometry Assay for Determination of Perampanel and Concomitant Antiepileptic Drugs in the Plasma of Patients With Epilepsy Compared With a Fluorescent HPLC Assay.
    de Grazia U; DʼUrso A; Ranzato F; De Riva V; Contarato G; Billo G; Perini F; Galloni E
    Ther Drug Monit; 2018 Aug; 40(4):477-485. PubMed ID: 29746395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Validation of an HPLC-UV Assay for the Therapeutic Monitoring of the New Antiepileptic Drug Perampanel in Human Plasma.
    Franco V; Marchiselli R; Fattore C; Tartara E; De Sarro G; Russo E; Perucca E
    Ther Drug Monit; 2016 Dec; 38(6):744-750. PubMed ID: 27753779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perampanel, an antagonist of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, for the treatment of epilepsy: studies in human epileptic brain and nonepileptic brain and in rodent models.
    Zwart R; Sher E; Ping X; Jin X; Sims JR; Chappell AS; Gleason SD; Hahn PJ; Gardinier K; Gernert DL; Hobbs J; Smith JL; Valli SN; Witkin JM
    J Pharmacol Exp Ther; 2014 Oct; 351(1):124-33. PubMed ID: 25027316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A high-performance liquid chromatography-tandem mass spectrometry method for quantification of perampanel in human plasma: Effect of concomitant anti-seizure medications on perampanel concentration in patients with epilepsy.
    Zhang YF; Yu Y; Zhong MK; Wu XY; Ma CL
    J Pharm Biomed Anal; 2023 Jan; 223():115155. PubMed ID: 36403349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An inter-laboratory cross-validation study for the determination of perampanel in human plasma by liquid chromatography assays.
    Mano Y
    Biomed Chromatogr; 2016 Dec; 30(12):2067-2069. PubMed ID: 27217163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and application of an HPLC-DAD technique for human plasma concentration monitoring of perampanel and lamotrigine in drug-resistant epileptic patients.
    Sabença R; Bicker J; Silva R; Carona A; Silva A; Santana I; Sales F; Falcão A; Fortuna A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jan; 1162():122491. PubMed ID: 33360678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validated assay for the simultaneous determination of cortisol and budesonide in human plasma using ultra high performance liquid chromatography-tandem mass spectrometry.
    Szeitz A; Manji J; Riggs KW; Thamboo A; Javer AR
    J Pharm Biomed Anal; 2014 Mar; 90():198-206. PubMed ID: 24389462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and brain uptake study of novel AMPA receptor antagonist perampanel in SD rats using a validated UHPLC-QTOF-MS method.
    Paul D; Allakonda L; Sahu A; Surendran S; Satheeshkumar N
    J Pharm Biomed Anal; 2018 Feb; 149():234-241. PubMed ID: 29127904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous determination of flurbiprofen and its hydroxy metabolite in human plasma by liquid chromatography-tandem mass spectrometry for clinical application.
    Lee HI; Choi CI; Byeon JY; Lee JE; Park SY; Kim YH; Kim SH; Lee YJ; Jang CG; Lee SY
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Nov; 971():58-63. PubMed ID: 25264913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of second-generation antidepressant drug, sertraline and its active metabolite, N-desmethyl sertraline in human plasma by a sensitive and selective liquid chromatography-tandem mass spectrometry method.
    Patel BN; Sharma N; Sanyal M; Shrivastav PS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jan; 877(3):221-9. PubMed ID: 19109078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous quantification of niacin and its three main metabolites in human plasma by LC-MS/MS.
    Liu M; Zhang D; Wang X; Zhang L; Han J; Yang M; Xiao X; Zhang Y; Liu H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Sep; 904():107-14. PubMed ID: 22884475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perampanel, a selective, noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: interim results from phase III, extension study 307.
    Krauss GL; Perucca E; Ben-Menachem E; Kwan P; Shih JJ; Squillacote D; Yang H; Gee M; Zhu J; Laurenza A
    Epilepsia; 2013 Jan; 54(1):126-34. PubMed ID: 22905878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Method development, validation and bioequivalence of varenicline in human plasma by liquid chromatography tandem mass spectrometry.
    Al-Haj A; Alawi M; Arafat T; Hourani MK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jul; 931():134-9. PubMed ID: 23774248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid chromatographic-electrospray tandem mass spectrometric determination of clarithromycin in human plasma.
    Li W; Rettig J; Jiang X; Francisco DT; Naidong W
    Biomed Chromatogr; 2006 Nov; 20(11):1242-51. PubMed ID: 16838265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A highly sensitive and selective method for the determination of leukotriene B4 (LTB4) in ex vivo stimulated human plasma by ultra fast liquid chromatography-tandem mass spectrometry.
    Lin W; Huang MQ; Xue X; Bertelsen K; Chen G; Zhao H; Lin ZJ; Fourie A; de Jong J; Weng N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Apr; 925():54-62. PubMed ID: 23523878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative determination and pharmacokinetic study of the novel anti-Parkinson's disease candidate drug FLZ in rat brain by high performance liquid chromatography-tandem mass spectrometry.
    Hou J; Qu F; Wu C; Ren Q; Zhang J
    J Pharm Biomed Anal; 2012 Jul; 66():232-9. PubMed ID: 22472186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous determination of a selective adenosine 2A agonist, BMS-068645, and its acid metabolite in human plasma by liquid chromatography-tandem mass spectrometry--evaluation of the esterase inhibitor, diisopropyl fluorophosphate, in the stabilization of a labile ester-containing drug.
    Zeng J; Onthank D; Crane P; Unger S; Zheng N; Pasas-Farmer S; Arnold M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):77-84. PubMed ID: 17280881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous quantification of dabrafenib and trametinib in human plasma using high-performance liquid chromatography-tandem mass spectrometry.
    Nijenhuis CM; Haverkate H; Rosing H; Schellens JH; Beijnen JH
    J Pharm Biomed Anal; 2016 Jun; 125():270-9. PubMed ID: 27058232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.